{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:51:21Z","timestamp":1790563881125,"version":"4.1.0"},"reference-count":87,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>This study aims to assess the prognostic value of the fatty liver index (FLI), a noninvasive tool for hepatic steatosis assessment, in predicting all-cause and disease-specific mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We linked data from the National Health and Nutrition Examination Survey III (1988\u20131994) with Public-Use Mortality Files, forming a cohort of 11\u2005297 participants with a median follow-up period of 26.25\u2005years. Cox proportional hazards models were used to evaluate the association between FLI and all-cause mortality, while Fine and Gray\u2019s models assessed the relationship between FLI and disease-specific mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The FLI\u2005\u2265\u200560 was independently associated with an increased risk of all-cause mortality (hazard ratio\u2005=\u20051.24, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001), as well as mortality from malignant neoplasms (hazard ratio\u2005=\u20051.18, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.048), diabetes (hazard ratio\u2005=\u20052.62, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.001), and cardiovascular diseases (CVDs) (hazard ratio\u2005=\u20051.18, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.018), compared to FLI\u2005&lt;\u200530. No significant associations were found with Alzheimer\u2019s disease, influenza and pneumonia, chronic lower respiratory diseases, or renal disorders. Subgroup analyses indicated that individuals who were females aged 40\u201360 (hazard ratio\u2005=\u20051.67, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.003), non-overweight (hazard ratio\u2005=\u20051.75, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.007), or without abdominal obesity (hazard ratio\u2005=\u20051.75, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.007) exhibited a stronger association between FLI\u2005\u2265\u200560 and all-cause mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>These findings support the prognostic value of the FLI for predicting mortality from all causes, malignant neoplasms, diabetes, and CVDs. Targeted attention is needed in postmenopausal women, non-overweight, and non-abdominally obese populations.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/meg.0000000000002865","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T11:03:56Z","timestamp":1728903836000},"page":"1453-1463","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Fatty liver index as an independent predictor of all-cause and disease-specific mortality"],"prefix":"10.1097","volume":"36","author":[{"given":"Ruixin","family":"Zhang","sequence":"first","affiliation":[{"name":"School of Public Health, Xiamen University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhao","family":"Ren","sequence":"additional","affiliation":[{"name":"School of Public Health, Xiamen University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Mi","sequence":"additional","affiliation":[{"name":"Department of Public Health, Zhongshan Hospital, Fudan University (Xiamen Branch)"},{"name":"Department of Public Health, Xiamen Clinical Research Center for Cancer Therapy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hospital Infection Control"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingjuan","family":"He","sequence":"additional","affiliation":[{"name":"Department of Public Health, Zhongshan Hospital, Fudan University (Xiamen Branch)"},{"name":"Department of Public Health, Xiamen Clinical Research Center for Cancer Therapy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renyan","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Public Health, Xiamen University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University (Xiamen Branch), Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghao","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Public Health, Zhongshan Hospital, Fudan University (Xiamen Branch)"},{"name":"Department of Public Health, Xiamen Clinical Research Center for Cancer Therapy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"R1-20250801","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R2-20250801","doi-asserted-by":"crossref","first-page":"1087260","DOI":"10.3389\/fendo.2022.1087260","article-title":"Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD).","volume":"13","author":"Rong","year":"2022","journal-title":"Front Endocrinol"},{"key":"R3-20250801","doi-asserted-by":"crossref","first-page":"e0251","DOI":"10.1097\/HC9.0000000000000251","article-title":"The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019.","volume":"7","author":"Paik","year":"2023","journal-title":"Hepatol Commun"},{"key":"R4-20250801","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","article-title":"Metabolic dysfunction-associated steatotic liver disease: update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease.","volume":"79","author":"Kanwal","year":"2024","journal-title":"Hepatology"},{"key":"R5-20250801","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease.","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"R6-20250801","first-page":"7","article-title":"Diagnostic accuracy of ultrasonography for the detection of hepatic steatosis: an updated meta-analysis of observational studies.","volume":"1","author":"Ballestri","year":"2021","journal-title":"Metab Target Organ Damage"},{"key":"R7-20250801","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis.","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"},{"key":"R8-20250801","doi-asserted-by":"crossref","first-page":"101167","DOI":"10.1016\/j.molmet.2021.101167","article-title":"Imaging biomarkers of NAFLD, NASH, and fibrosis.","volume":"50","author":"Ajmera","year":"2021","journal-title":"Mol Metab"},{"key":"R9-20250801","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population.","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"R10-20250801","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","article-title":"Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.","volume":"137","author":"Kotronen","year":"2009","journal-title":"Gastroenterology"},{"key":"R11-20250801","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease.","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"key":"R12-20250801","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/apt.13012","article-title":"Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey.","volume":"41","author":"Ruhl","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R13-20250801","doi-asserted-by":"crossref","first-page":"16494","DOI":"10.1038\/srep16494","article-title":"ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population.","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"key":"R14-20250801","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.cgh.2020.01.020","article-title":"Dallas Steatosis Index identifies patients with nonalcoholic fatty liver disease.","volume":"18","author":"McHenry","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R15-20250801","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1007\/s12325-020-01493-w","article-title":"A new, non-invasive scale for steatosis developed using real-world data from Russian outpatients to aid in the diagnosis of non-alcoholic fatty liver disease.","volume":"37","author":"Maev","year":"2020","journal-title":"Adv Ther"},{"key":"R16-20250801","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/MEG.0000000000002497","article-title":"Validation of nonalcoholic fatty liver disease (NAFLD) related steatosis indices in metabolic associated fatty liver disease (MAFLD) and comparison of the diagnostic accuracy between NAFLD and MAFLD.","volume":"35","author":"Chen","year":"2023","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R17-20250801","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13293-024-00617-z","article-title":"Fatty Liver Index (FLI) is the best score to predict MASLD with 50% lower cut-off value in women than in men.","volume":"15","author":"Crudele","year":"2024","journal-title":"Biol Sex Differ"},{"key":"R18-20250801","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1507\/endocrj.EJ17-0466","article-title":"Validation of simple indexes for nonalcoholic fatty liver disease in western China: a retrospective cross-sectional study.","volume":"65","author":"Zhu","year":"2018","journal-title":"Endocr J"},{"key":"R19-20250801","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/jgh.15799","article-title":"Validation of five hepatic steatosis algorithms in metabolic-associated fatty liver disease: a population based study.","volume":"37","author":"Liu","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"R20-20250801","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.3390\/diagnostics13213316","article-title":"The role of the fatty liver index (FLI) in the management of non-alcoholic fatty liver disease: a systematic review.","volume":"13","author":"Biciusca","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R21-20250801","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement.","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"R22-20250801","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1038\/s41598-023-32129-y","article-title":"Application of machine learning in predicting non-alcoholic fatty liver disease using anthropometric and body composition indices.","volume":"13","author":"Razmpour","year":"2023","journal-title":"Sci Rep"},{"key":"R23-20250801","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.2147\/DMSO.S429963","article-title":"The combination of remnant cholesterol and waist circumference offers predictive value for nonalcoholic fatty liver disease: a cross-sectional study from a medical examination center.","volume":"16","author":"Jia","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R24-20250801","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics.","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"R25-20250801","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3892\/br.2014.309","article-title":"Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes.","volume":"2","author":"Tomizawa","year":"2014","journal-title":"Biomed Rep"},{"key":"R26-20250801","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/s12876-022-02598-y","article-title":"Assessing the longitudinal association between the GGT\/HDL-C ratio and NAFLD: a cohort study in a non-obese Chinese population.","volume":"22","author":"Xie","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"R27-20250801","doi-asserted-by":"crossref","first-page":"17","DOI":"10.20517\/mtod.2022.20","article-title":"Concise review: gamma-glutamyl transferase \u2013 evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk.","volume":"2","author":"Lonardo","year":"2022","journal-title":"Metab Target Organ Damage"},{"issue":"Suppl 1","key":"R28-20250801","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease.","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"key":"R29-20250801","first-page":"10","article-title":"The fatty liver index (FLI) 15 years later: a reappraisal.","volume":"1","author":"Lonardo","year":"2021","journal-title":"Metab Target Organ Damage"},{"key":"R30-20250801","doi-asserted-by":"crossref","first-page":"638615","DOI":"10.3389\/fendo.2021.638615","article-title":"The repeatedly elevated fatty liver index is associated with increased mortality: a population-based cohort study.","volume":"12","author":"Lee","year":"2021","journal-title":"Front Endocrinol"},{"key":"R31-20250801","doi-asserted-by":"crossref","first-page":"e0287467","DOI":"10.1371\/journal.pone.0287467","article-title":"Fatty liver index and mortality after myocardial infarction: a prospective analysis in the alpha omega cohort.","volume":"18","author":"Heerkens","year":"2023","journal-title":"PLoS One"},{"key":"R32-20250801","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.clnu.2024.02.006","article-title":"Non-invasive tools for liver steatosis and steatohepatitis predict incidence of diabetes, cardiovascular disease and mortality 20 years later: the ATTICA cohort study (2002\u20132022).","volume":"43","author":"Kouvari","year":"2024","journal-title":"Clin Nutr"},{"key":"R33-20250801","first-page":"1","article-title":"Sample design: Third National Health and Nutrition Examination Survey.","volume":"2","author":"Ezzati","year":"1992","journal-title":"Vital Health Stat 2"},{"key":"R35-20250801","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12933-024-02171-9","article-title":"Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study.","volume":"23","author":"Garofolo","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"R36-20250801","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jad.2024.02.036","article-title":"The mediating role of obesity in the development of depression in individuals with diabetes: a population-based study from NHANES 2005\u20132014.","volume":"351","author":"Nong","year":"2024","journal-title":"J Affect Disord"},{"key":"R37-20250801","doi-asserted-by":"crossref","first-page":"836357","DOI":"10.3389\/fpubh.2022.836357","article-title":"Association between blood lead level with high blood pressure in US (NHANES 1999\u20132018).","volume":"10","author":"Huang","year":"2022","journal-title":"Front Public Health"},{"key":"R38-20250801","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.3390\/nu15204434","article-title":"Adequate intake of dietary fiber may relieve the detrimental impact of blood lead on dyslipidemia among US adults: a study of data from the National Health and Nutrition Examination Survey Database.","volume":"15","author":"Li","year":"2023","journal-title":"Nutrients"},{"key":"R39-20250801","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"key":"R40-20250801","doi-asserted-by":"crossref","first-page":"188","DOI":"10.37349\/edd.2023.00026","article-title":"Principles of risk stratification in nonalcoholic fatty liver disease. A narrative review emphasizing non-invasive strategies.","volume":"2","author":"Lonardo","year":"2023","journal-title":"Explor Dig Dis"},{"key":"R41-20250801","doi-asserted-by":"crossref","first-page":"1","DOI":"10.20517\/mtod.2022.23","article-title":"Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality.","volume":"3","author":"Ballestri","year":"2023","journal-title":"Metab Target Organ Damage"},{"key":"R42-20250801","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/liv.15801","article-title":"Liver stiffness as a cornerstone in heart disease risk assessment.","volume":"44","author":"Boeckmans","year":"2024","journal-title":"Liver Int"},{"key":"R43-20250801","doi-asserted-by":"crossref","first-page":"100896","DOI":"10.1016\/j.jhepr.2023.100896","article-title":"Role of fatty liver index in risk-stratifying comorbid disease outcomes in non-alcoholic fatty liver disease.","volume":"5","author":"Ho","year":"2023","journal-title":"JHEP Rep"},{"key":"R44-20250801","doi-asserted-by":"crossref","first-page":"11124","DOI":"10.1038\/s41598-019-47687-3","article-title":"Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis.","volume":"9","author":"Liu","year":"2019","journal-title":"Sci Rep"},{"key":"R45-20250801","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/MEG.0000000000002719","article-title":"Metabolic dysfunction-associated steatotic liver disease and the risk of mortality in individuals with type 2 diabetes: a systematic review and meta-analysis.","volume":"36","author":"Wongtrakul","year":"2024","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R46-20250801","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.26156","article-title":"Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.","volume":"57","author":"Kim","year":"2013","journal-title":"Hepatology"},{"key":"R47-20250801","doi-asserted-by":"crossref","first-page":"d6891","DOI":"10.1136\/bmj.d6891","article-title":"Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study.","volume":"343","author":"Lazo","year":"2011","journal-title":"BMJ"},{"key":"R48-20250801","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/hep.28390","article-title":"Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.","volume":"63","author":"Unalp-Arida","year":"2016","journal-title":"Hepatology"},{"key":"R49-20250801","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S2213-8587(18)30288-2","article-title":"Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK.","volume":"6","author":"Bhaskaran","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R50-20250801","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archinternmed.2010.201","article-title":"Waist circumference and all-cause mortality in a large US cohort.","volume":"170","author":"Jacobs","year":"2010","journal-title":"Arch Intern Med"},{"key":"R51-20250801","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/s41598-022-25970-0","article-title":"Gamma-glutamyl transferase and risk of all-cause and disease-specific mortality: a nationwide cohort study.","volume":"13","author":"Cho","year":"2023","journal-title":"Sci Rep"},{"key":"R52-20250801","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1476-511X-12-159","article-title":"Effects of blood triglycerides on cardiovascular and all-cause mortality: a systematic review and meta-analysis of 61 prospective studies.","volume":"12","author":"Liu","year":"2013","journal-title":"Lipids Health Dis"},{"key":"R53-20250801","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/jgh.15815","article-title":"Association of the serum transaminase with mortality among the US elderly population.","volume":"37","author":"Ke","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"R54-20250801","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12944-020-01400-w","article-title":"A dose-independent association of triglyceride levels with all-cause mortality among adults population.","volume":"19","author":"Huang","year":"2020","journal-title":"Lipids Health Dis"},{"key":"R55-20250801","doi-asserted-by":"crossref","first-page":"102292","DOI":"10.1016\/j.eclinm.2023.102292","article-title":"Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study.","volume":"65","author":"Moon","year":"2023","journal-title":"EClinicalMedicine"},{"key":"R56-20250801","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/gutjnl-2020-322572","article-title":"Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals.","volume":"70","author":"Mantovani","year":"2021","journal-title":"Gut"},{"key":"R57-20250801","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1080\/07853890.2021.1956685","article-title":"Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).","volume":"53","author":"Cuthbertson","year":"2021","journal-title":"Ann Med"},{"key":"R58-20250801","doi-asserted-by":"crossref","first-page":"3920196","DOI":"10.1155\/2020\/3920196","article-title":"The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD).","volume":"2020","author":"Tanase","year":"2020","journal-title":"J Diabetes Res"},{"key":"R59-20250801","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s13105-023-00991-z","article-title":"Fatty liver index (FLI): more than a marker of hepatic steatosis.","volume":"80","author":"Kaneva","year":"2024","journal-title":"J Physiol Biochem"},{"key":"R60-20250801","doi-asserted-by":"crossref","first-page":"e1095","DOI":"10.1210\/clinem\/dgad575","article-title":"Nonalcoholic fatty liver disease and the risk of thyroid cancer among young adults in South Korea.","volume":"109","author":"Kwon","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"R61-20250801","doi-asserted-by":"crossref","first-page":"12173","DOI":"10.1002\/cam4.5910","article-title":"Liver injury indicators and subsequent cancer development among non-fatty liver population.","volume":"12","author":"Ito","year":"2023","journal-title":"Cancer Med"},{"key":"R62-20250801","doi-asserted-by":"crossref","first-page":"e0226351","DOI":"10.1371\/journal.pone.0226351","article-title":"The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: national population-based cohort study.","volume":"15","author":"Lee","year":"2020","journal-title":"PLoS One"},{"key":"R63-20250801","doi-asserted-by":"crossref","first-page":"10681","DOI":"10.1038\/s41598-022-14856-w","article-title":"Increased risk of pancreatic cancer in individuals with non-alcoholic fatty liver disease.","volume":"12","author":"Park","year":"2022","journal-title":"Sci Rep"},{"key":"R64-20250801","doi-asserted-by":"crossref","first-page":"e0201308","DOI":"10.1371\/journal.pone.0201308","article-title":"Is nonalcoholic fatty liver disease associated with the development of prostate cancer? A nationwide study with 10,516,985 Korean men.","volume":"13","author":"Choi","year":"2018","journal-title":"PLoS One"},{"key":"R65-20250801","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3390\/ijms17050717","article-title":"Non-alcoholic fatty liver disease and extra-hepatic cancers.","volume":"17","author":"Sanna","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R66-20250801","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/DCR.0000000000000973","article-title":"The fatty liver index: a simple and accurate predictor of colorectal adenoma in an average-risk population.","volume":"61","author":"Ze","year":"2018","journal-title":"Dis Colon Rectum"},{"key":"R67-20250801","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jpsychires.2023.03.041","article-title":"NAFLD does not increase the risk of incident dementia: a prospective study and meta-analysis.","volume":"161","author":"Huang","year":"2023","journal-title":"J Psychiatr Res"},{"key":"R68-20250801","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3350\/cmh.2022.0259","article-title":"Non-alcoholic fatty liver disease and the risk of dementia: a meta-analysis of cohort studies.","volume":"28","author":"Lu","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"R69-20250801","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/toxsci\/kfac070","article-title":"Increased renal expression of complement components in patients with liver diseases: nonalcoholic steatohepatitis, alcohol-associated, viral hepatitis, and alcohol-viral combination.","volume":"189","author":"Frost","year":"2022","journal-title":"Toxicol Sci"},{"key":"R70-20250801","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4254\/wjh.v15.i2.265","article-title":"Prevalence of non-alcoholic fatty liver disease in patients with nephrotic syndrome: a population-based study.","volume":"15","author":"Onwuzo","year":"2023","journal-title":"World J Hepatol"},{"key":"R71-20250801","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/qjmed\/hcy227","article-title":"Non-alcoholic fatty liver disease and 30-day all-cause mortality in adult patients with community-acquired pneumonia.","volume":"112","author":"Nseir","year":"2019","journal-title":"QJM"},{"key":"R72-20250801","first-page":"198","article-title":"Association between non-alcoholic fatty liver disease and hospitalized patients with community-acquired pneumonia.","volume":"19","author":"Nseir","year":"2017","journal-title":"Isr Med Assoc J"},{"key":"R73-20250801","doi-asserted-by":"crossref","first-page":"100320","DOI":"10.1016\/j.aohep.2021.100320","article-title":"Hepatic steatosis and respiratory diseases: a new panorama.","volume":"24","author":"Botello-Manilla","year":"2021","journal-title":"Ann Hepatol"},{"key":"R74-20250801","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/ndt\/gfac266","article-title":"Association between the fatty liver index and chronic kidney disease: the population-based KORA study.","volume":"38","author":"Cai","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"R75-20250801","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gutjnl-2020-323082","article-title":"Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis.","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"key":"R76-20250801","doi-asserted-by":"crossref","first-page":"10822","DOI":"10.1038\/s41598-024-61696-x","article-title":"Association of hepatic steatosis and liver fibrosis with chronic obstructive pulmonary disease among adults.","volume":"14","author":"Zheng","year":"2024","journal-title":"Sci Rep"},{"key":"R77-20250801","doi-asserted-by":"crossref","first-page":"6","DOI":"10.20517\/mtod.2022.06","article-title":"Chronic obstructive pulmonary disease (COPD) and metabolic fatty liver syndromes: a dangerous but neglected liaison.","volume":"2","author":"Lonardo","year":"2022","journal-title":"Metab Target Organ Damage"},{"key":"R78-20250801","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12876-019-0972-6","article-title":"Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States.","volume":"19","author":"Golabi","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"R79-20250801","doi-asserted-by":"crossref","first-page":"638615","DOI":"10.3389\/fendo.2021.638615","article-title":"The repeatedly elevated fatty liver index is associated with increased mortality: a population-based cohort study.","volume":"12","author":"Lee","year":"2021","journal-title":"Front Endocrinol"},{"key":"R80-20250801","doi-asserted-by":"crossref","first-page":"20406223221122478","DOI":"10.1177\/20406223221122478","article-title":"Association of NAFLD with cardiovascular disease and all-cause mortality: a large-scale prospective cohort study based on UK Biobank.","volume":"13","author":"Ma","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"key":"R81-20250801","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps.","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"R82-20250801","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2265.2006.02543.x","article-title":"Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial.","volume":"65","author":"McKenzie","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R83-20250801","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41574-020-00431-8","article-title":"Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver.","volume":"17","author":"Goossens","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"R84-20250801","doi-asserted-by":"crossref","first-page":"S-909","DOI":"10.1016\/S0016-5085(14)63307-2","article-title":"379 characteristics and long-term prognosis of lean patients with nonalcoholic fatty liver disease.","volume":"146","author":"Dela Cruz","year":"2014","journal-title":"Gastroenterology"},{"key":"R85-20250801","doi-asserted-by":"crossref","first-page":"101288","DOI":"10.1016\/j.aohep.2024.101288","article-title":"Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: an updated meta-analysis.","volume":"29","author":"Wongtrakul","year":"2024","journal-title":"Ann Hepatol"},{"key":"R86-20250801","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ajg.2016.318","article-title":"Clinical and metabolic characterization of lean Caucasian subjects with non-alcoholic fatty liver.","volume":"112","author":"Feldman","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"R87-20250801","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/HEP.0000000000000329","article-title":"Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study).","volume":"78","author":"Nabi","year":"2023","journal-title":"Hepatology"},{"key":"R88-20250801","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s40001-024-01833-4","article-title":"Specific mortality in patients with diffuse large B-cell lymphoma: a retrospective analysis based on the surveillance, epidemiology, and end results database.","volume":"29","author":"Xu","year":"2024","journal-title":"Eur J Med Res"}],"container-title":["European Journal of Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000002865","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T17:01:42Z","timestamp":1754067702000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000002865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":87,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0000000000002865","relation":{},"ISSN":["0954-691X","1473-5687"],"issn-type":[{"value":"0954-691X","type":"print"},{"value":"1473-5687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]}}}